Giovanni Roti

2.9k total citations · 1 hit paper
57 papers, 1.5k citations indexed

About

Giovanni Roti is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Giovanni Roti has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Hematology and 17 papers in Oncology. Recurrent topics in Giovanni Roti's work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (13 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Giovanni Roti is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (13 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Giovanni Roti collaborates with scholars based in Italy, United States and France. Giovanni Roti's co-authors include Kimberly Stegmaier, Cristina Mecucci, Matteo Marchesini, Andrew L. Kung, Paolo Gorello, Roberto Rosati, Kenneth N. Ross, Brunangelo Falini, Maria Paola Martelli and Daniela Diverio and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Giovanni Roti

52 papers receiving 1.4k citations

Hit Papers

Acute lymphoblastic leukaemia 2024 2026 2025 2024 10 20 30 40 50

Peers

Giovanni Roti
Yi Hua Qiu United States
Marianne E. Greene United States
Elie Traer United States
L-J Gu China
Yi Hua Qiu United States
Giovanni Roti
Citations per year, relative to Giovanni Roti Giovanni Roti (= 1×) peers Yi Hua Qiu

Countries citing papers authored by Giovanni Roti

Since Specialization
Citations

This map shows the geographic impact of Giovanni Roti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Roti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Roti more than expected).

Fields of papers citing papers by Giovanni Roti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Roti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Roti. The network helps show where Giovanni Roti may publish in the future.

Co-authorship network of co-authors of Giovanni Roti

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Roti. A scholar is included among the top collaborators of Giovanni Roti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Roti. Giovanni Roti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorusso, Bruno, Giovanni Roti, Sabrina Bonomini, et al.. (2024). CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase. International Journal of Molecular Sciences. 25(18). 9760–9760.
2.
Pozzi, Giulia, Cristina Mancini, Eugenia Martella, et al.. (2024). Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis. SHILAP Revista de lepidopterología. 3.
3.
Chen, Sai‐Juan, Daniel Herranz, Cristina Mecucci, et al.. (2024). Acute lymphoblastic leukaemia. Nature Reviews Disease Primers. 10(1). 41–41. 52 indexed citations breakdown →
4.
Keppeler, Hildegard, et al.. (2023). Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia. International Journal of Molecular Sciences. 24(19). 14466–14466. 1 indexed citations
5.
Li, Stephanie, et al.. (2021). Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights. The Journal of Clinical Endocrinology & Metabolism. 106(12). 3569–3590. 13 indexed citations
6.
Mazzaschi, Giulia, Gianluca Milanese, Denise Madeddu, et al.. (2021). Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients. Tumori Journal. 108(1). 86–92. 6 indexed citations
7.
Marchesini, Matteo, et al.. (2021). Targeting oncogenic Notch signaling with SERCA inhibitors. Journal of Hematology & Oncology. 14(1). 8–8. 53 indexed citations
8.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 31. 105781–105781. 5 indexed citations
9.
Pierini, Valentina, Paolo Gorello, Giovanni Roti, et al.. (2020). New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma. Acta Neuropathologica Communications. 8(1). 145–145. 22 indexed citations
10.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC. Lung Cancer. 144. 30–39. 27 indexed citations
11.
Lella, Filippo Di, et al.. (2019). Bilateral tonsillar infiltration of T‐cell prolymphocytic leukemia. SHILAP Revista de lepidopterología. 7(11). 2250–2251. 1 indexed citations
12.
Place, Andrew E., Yana Pikman, Kristen E. Stevenson, et al.. (2018). Phase I trial of the mTOR inhibitor everolimus in combination with multi‐agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 65(7). e27062–e27062. 43 indexed citations
13.
Starza, Roberta La, Lorenza Pastorino, Elisabetta Albi, et al.. (2018). Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin. Molecular Cytogenetics. 11(1). 6–6. 3 indexed citations
14.
Su, Angela, Franco Aversa, Birgit Knoechel, et al.. (2017). Identification of EHMT2 As a New Target in T-Cell Acute Lymphoblastic Leukemia. Blood. 130. 2548–2548. 1 indexed citations
15.
Pikman, Yana, Gabriela Alexe, Giovanni Roti, et al.. (2016). Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 23(4). 1012–1024. 81 indexed citations
16.
Roti, Giovanni & Kimberly Stegmaier. (2014). New Approaches to Target T-ALL. Frontiers in Oncology. 4. 170–170. 40 indexed citations
17.
Frumm, Stacey M., Zi Peng Fan, Kenneth N. Ross, et al.. (2013). Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation. Chemistry & Biology. 20(5). 713–725. 85 indexed citations
18.
Banerji, Versha, Stacey M. Frumm, Kenneth N. Ross, et al.. (2012). The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia. Journal of Clinical Investigation. 122(3). 935–947. 85 indexed citations
19.
Roti, Giovanni & Kimberly Stegmaier. (2011). Targeting NOTCH1 in Hematopoietic Malignancy. Critical Reviews™ in Oncogenesis. 16(1-2). 103–115. 9 indexed citations
20.
Bolli, Niccolò, Sara Galimberti, Maria Paola Martelli, et al.. (2006). Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia. The Lancet Oncology. 7(4). 350–352. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026